09Sep 2023
Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer

Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer

Human papillomavirus-positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) is rising, surpassing cervical cancer as the predominant HPV-induced cancer in developed regions. While standard treatments yield positive outcomes for HPV+ OPSCC patients, the focus is shifting toward reducing treatment intensity. However, recent multi-centre trials failed to establish the non-inferiority of de-escalation strategies at a population level, emphasizing the need for precision medicine. This review explores the heterogeneity within HPV+ OPSCC, seeking biomarkers for patient stratification and personalized treatment. It delves into clinical, morphological, and molecular perspectives, examining the challenges and potential future directions, including addressing racial and ethnic differences.

  • #oncology

Like

Save

Share